Physician profile
Sachin Dhingra
NPI 1407041007
$2,853.18
in general payments reported to CMS, 2019-2025
18 companies · $581 in 2025
The $581 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $393 · 2021: $493 · 2022: $186 · 2023: $413 · 2024: $165 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,400.14 | 2019-2023 | |
| Cranial Technologies, INC | $233.31 | 2022-2025 | Doc Band |
| Organon LLC | $198.77 | 2025 | |
| Merck Sharp & Dohme LLC | $183.66 | 2023-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Kowa Pharmaceuticals America, INC. | $156.22 | 2025 | Zoryve |
| Phadia US INC. | $138.04 | 2019-2023 | Immunocap |
| Sobi, INC | $135.89 | 2019-2023 | |
| Glaxosmithkline, LLC. | $100.47 | 2021-2025 | Bexsero, Rotarix, Penmenvy |
| Ars Pharmaceuticals Operations, INC. | $51.67 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $42.64 | 2021 | |
| Alk-Abello, INC | $39.42 | 2023 | Odactra, Grastek, Ragwitek |
| Sanofi-Aventis U.S. LLC | $37.68 | 2024-2025 | |
| Circassia INC. | $32.06 | 2020 | |
| Aimmune Therapeutics, INC. | $22.87 | 2021 | |
| Shire North American Group INC | $20.76 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $20.70 | 2022 | |
| Seqirus USA INC | $20.16 | 2025 | Flucelvax |
| Ultragenyx Pharmaceutical INC. | $18.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachin Dhingra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.